245 related articles for article (PubMed ID: 30802950)
1. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease.
Jha NK; Jha SK; Kar R; Nand P; Swati K; Goswami VK
J Neurochem; 2019 Jul; 150(2):113-137. PubMed ID: 30802950
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
El-Araby RE; Wasif K; Johnson R; Tu Q; Aboushousha T; Zhu ZX; Chen J
Exp Neurol; 2024 Aug; 378():114820. PubMed ID: 38789025
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
5. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.
Uddin MS; Hasana S; Ahmad J; Hossain MF; Rahman MM; Behl T; Rauf A; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(3):402-414. PubMed ID: 33213314
[TBL] [Abstract][Full Text] [Related]
6. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
7. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease.
Sun E; Motolani A; Campos L; Lu T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012242
[TBL] [Abstract][Full Text] [Related]
8. Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity.
Jang SS; Chung HJ
Neural Plast; 2016; 2016():7969272. PubMed ID: 27019755
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
10. Altered glia-neuron communication in Alzheimer's Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.
Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
Cell Commun Signal; 2024 Jun; 22(1):317. PubMed ID: 38849813
[TBL] [Abstract][Full Text] [Related]
11. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
12. Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J; Thomson E; Chowdhury SR; Snow WM; Perez C; Wong TP; Fernyhough P; Albensi BC
Neuroscience; 2017 Oct; 361():81-92. PubMed ID: 28802916
[TBL] [Abstract][Full Text] [Related]
13. Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.
Sharman MJ; Verdile G; Kirubakaran S; Parenti C; Singh A; Watt G; Karl T; Chang D; Li CG; Münch G
CNS Drugs; 2019 May; 33(5):457-480. PubMed ID: 30900203
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
16. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of Nanodiamond in Alzheimer's Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling.
Alawdi SH; El-Denshary ES; Safar MM; Eidi H; David MO; Abdel-Wahhab MA
Mol Neurobiol; 2017 Apr; 54(3):1906-1918. PubMed ID: 26897372
[TBL] [Abstract][Full Text] [Related]
19. Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease.
Snow WM; Albensi BC
Front Mol Neurosci; 2016; 9():118. PubMed ID: 27881951
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
